The ITA.LI.CA Staging System: A Novel Staging System for Hepatocellular Carcinoma

Neehar D Parikh; Amit G Singal

doi:10.1371/journal.pmed.1002005

The ITA.LI.CA Staging System: A Novel Staging System for Hepatocellular Carcinoma

PLoS Med. 2016 Apr 26;13(4):e1002005. doi: 10.1371/journal.pmed.1002005. eCollection 2016 Apr.

Authors

Neehar D Parikh¹, Amit G Singal^{2

3}

Affiliations

¹ Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan, United States of America.
² Department of Internal Medicine, UT Southwestern Medical Center, Dallas, Texas, United States of America.
³ Harold C. Simmons Cancer Center, UT Southwestern Medical Center, Dallas, Texas, United States of America.

Abstract

In this Perspective, Neehar Parikh and Amit Singal discuss the advantages of the ITA.LI.CA staging system for prognoses of liver cancer developed by Alessandro Vitale and colleagues.

Publication types

Comment

MeSH terms

Carcinoma, Hepatocellular / blood*
Carcinoma, Hepatocellular / secondary*
Female
Humans
Liver Neoplasms / blood*
Liver Neoplasms / pathology*
Male
Neoplasm Staging / methods*
alpha-Fetoproteins / analysis*

Substances

AFP protein, human
alpha-Fetoproteins

Grants and funding

The authors received no specific funding for this Perspective.